ArticleLangenbeck's archives of surgery2026
The quality and safety of establishing Ireland's first robotic adrenalectomy program: a single centre experience.
Article in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic adrenalectomy offers several technical advantages over conventional laparoscopy, particularly for lesions located adjacent to major vascular structures. However, data regarding the establishment of new robotic adrenalectomy programmes remains limited. This study aimed to evaluate the safety, feasibility, and early outcomes of implementing the first robotic adrenalectomy programme in the Republic of Ireland.
methodsA retrospective review of the first 50 consecutive patients who underwent robotic adrenalectomy between November 2021 and December 2024 at a tertiary endocrine surgery referral centre was performed. Clinical, pathological, and perioperative outcomes were analysed. Continuous variables were compared using Student's t-test or Mann-Whitney U test, and multivariable linear regression was used to assess factors associated with operative duration.
resultsThe mean age was 58.3 years, and 72% of patients were male. Median body mass index was 29.1 kg/m². The most common indications for surgery were phaeochromocytoma (32%), Cushing's syndrome (22%), and non-functioning lesions (18%). Median operative duration was 120 min (range 80-210). Conversion to open surgery occurred in 1 patient (2%), and intraoperative complications occurred in 3 patients (6%). Mean length of stay was 4.0 days. Postoperative morbidity was low, with four Clavien-Dindo grade II complications and one grade IIIa complication. There were no 30-day mortalities, reoperations, or readmissions. Complete (R0) resection was achieved in 94% of cases. Patients with larger tumours had longer operative duration and length of stay, whereas elevated BMI was not associated with increased operative duration.
conclusionsRobotic adrenalectomy is a safe and feasible minimally invasive approach that can be successfully implemented within a tertiary referral endocrine surgery centre, with low morbidity, low conversion rates, and acceptable pathological outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.